Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Jacqui Wise
| The first 150 words of the full text of this article appear below. |
A new antenatal screening test for Down's syndrome is now available in Britain. The integrated test combines blood tests and an ultrasound scan to produce a single estimate of the woman's risk of having a child with Down's syndrome.
The new test uses a woman's age, two measurements taken between 10 and 13 weeks of pregnancy (a nuchal translucency ultrasound measurement of the fetus and the level of pregnancy associated plasma protein A in the woman's blood), and the measurement of four substances in the woman's blood taken two to four weeks later (a fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, and inhibin A).
Nick Wald, professor of environmental and preventive medicine at the Wolfson Institute of Preventive Medicine in London, said: "The integrated test is more effective than any other Down's syndrome screening method currently available. It captures the advantages of the different options into a single test."
The integrated test detects
Read all Rapid Responses